Alzheimer's Disease Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Development and Validation of a Novel Functional Eye-Tracking Software Application for Alzheimer's Disease
Recruiting
  • Alzheimer's Disease
  • Eye-Tracking
  • Montréal, Quebec, Canada
    The Douglas Research Centre
2022-04-06
Apr 6, 2022
A
A Double-Blind, Placebo-Controlled, Dose Ranging Study of Xanamem® in Healthy Elderly Volunteers - 2022
Completed
  • Mild Cognitive Impairment
  • Alzheimer's Disease
  • Xanamem® 5 mg
  • +2 more
  • Bruce, Australian Capital Territory, Australia
  • +4 more
2022-04-06
Apr 6, 2022
N
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Recruiting
  • Dementia
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Intermittent Calorie Restriction, Insulin Resistance, and Biomarkers of Brain Function
Recruiting
  • Alzheimer's Disease
  • +2 more
  • Boost 5-2 diet
  • Healthy Living Diet
  • Baltimore, Maryland
    National Institute of Aging, Clinical Research Unit
2022-04-07
Apr 7, 2022
U
aeRobic Exercise and Cognitive Health - 2016
Completed
Has Results
  • Alzheimer's Disease
  • Aging
  • Enhanced Physical Activity
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
2022-04-01
Apr 1, 2022
B
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Not yet recruiting
  • Alzheimer's Disease
  • (no location specified)
2022-03-25
Mar 25, 2022
U
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
Recruiting
  • Alzheimer's Disease
  • Placebo
  • Bepranemab
  • Fresno, California
  • +93 more
2022-03-31
Mar 31, 2022
J
Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study
Active, not recruiting
  • Alzheimer's Disease
  • Plaque, Amyloid
    • Edinburgh, United Kingdom
    • +1 more
    2022-03-30
    Mar 30, 2022
    M
    MK-8189 Safety and Tolerability in Participants With Alzheimer's Disease With or Without Symptoms of Agitation-Aggression and/or Psychosis (MK-8189-017)
    Not yet recruiting
    • Alzheimer's Disease
    • (no location specified)
    2022-03-15
    Mar 15, 2022
    B
    A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
    Active, not recruiting
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +296 more
    2022-03-14
    Mar 14, 2022
    D
    Effect of REST in the Alzheimer Disease Continuum - 2020
    Completed
    • Alzheimer's Disease
      • Beijing, Beijing, China
        Dongzhimen Hospital,Beijing University of Chinese Medicine
      2022-03-22
      Mar 22, 2022
      A
      Prazosin for Agitation in Alzheimer's Disease - 2022
      Completed
      • Alzheimer's Disease
      • Disruptive Behavior
      • Sun City, Arizona
      • +13 more
      2022-03-18
      Mar 18, 2022
      T
      Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease
      Recruiting
      • Alzheimer's Disease
      • Scottsdale, Arizona
      • +19 more
      2022-03-21
      Mar 21, 2022
      G
      A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease - 2021
      Terminated
      Has Results
      • Alzheimer's Disease
      • Birmingham, Alabama
      • +132 more
      2022-02-16
      Feb 16, 2022
      G
      A Study of Semorinemab in Patients With Moderate Alzheimer's Disease
      Active, not recruiting
      • Alzheimer's Disease
      • Garden Grove, California
      • +48 more
      2022-02-28
      Feb 28, 2022
      N
      A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.
      Recruiting
      • Alzheimer's Disease
      • Bangalore, Karnataka, India
      • +8 more
      2022-03-10
      Mar 10, 2022
      G
      A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort
      Active, not recruiting
      • Alzheimer's Disease
      • Armenia, Colombia
      • +3 more
      2022-03-07
      Mar 7, 2022
      N
      Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
      Not yet recruiting
      • Alzheimer's Disease
      • Piromelatine 20 mg
      • Placebo
      • (no location specified)
      2022-03-03
      Mar 3, 2022
      M
      Cognition Platform Study in Participants at Risk for Alzheimer's Disease (AD) (MK-0000-413)
      Recruiting
      • Alzheimer's Disease
      • Mild Cognitive Impairment
      • Long Beach, California
      • +6 more
      2022-03-02
      Mar 2, 2022
      U
      Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training - 2021
      Completed
      • Mild Cognitive Impairment
      • Alzheimer's Disease
      • Memory Training
      • Kundalini yoga and meditation
      • Los Angeles, California
        UCLA Semel Institute
      2022-02-25
      Feb 25, 2022
      Z
      Study on the Effect of 40 Hz Non-Invasive Light Therapy System
      Not yet recruiting
      • Alzheimer's Disease
      • Light Therapy System (LTS): Active Setting
      • Light Therapy System (LTS): Sham Setting
      • Roskilde, Denmark
        Zealand University Hospital
      2022-02-18
      Feb 18, 2022
      W
      Westlake Longevity Cohort
      Recruiting
      • Aging
      • +3 more
        • Lishui, Zhejiang, China
          Lishui City People's Hospital
        2022-02-21
        Feb 21, 2022
        A
        New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study
        Recruiting
        • Alzheimer's Disease
        • +2 more
          • Greenbelt, Maryland
            Neurological Medicine, PA
          2022-02-14
          Feb 14, 2022
          A
          Diagnosis and Monitoring of Disease Progression Using Deep Neuro Signatures
          Recruiting
          • Alzheimer's Disease
          • Mild Cognitive Impairment
            • Athens, Greece
              Nikaia Ag Panteleimon Hospital
            2022-02-10
            Feb 10, 2022
            W
            Dominantly Inherited Alzheimer Network (DIAN)
            Recruiting
            • Alzheimer's Disease
              • Jacksonville, Florida
              • +22 more
              2022-02-09
              Feb 9, 2022